Iqvia Holdings (IQV) Invested Capital (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Invested Capital came in at $22.3 billion in Q2 2026, up 4.81% year-over-year from $21.3 billion in Q2 2025, and up 0.53% quarter-over-quarter from $22.2 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Invested Capital (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Invested Capital across 15 years of filings, most recently posting $22.3 billion for Q2 2026.
- In Q2 2026, Invested Capital rose 4.81% year-over-year to $22.3 billion; the TTM figure through Jun 2026 stood at $22.3 billion (up 4.81% YoY), while the FY2025 annual figure was $22.4 billion, up 11.49% from the prior year.
- Invested Capital came in at $22.3 billion for Q2 2026 at Iqvia Holdings, up from $22.2 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $22.4 billion in Q4 2025 to a low of $18.1 billion in Q2 2022.
- Average Invested Capital over 5 years is $20.1 billion, with a median of $19.9 billion recorded in 2024.
- Year-over-year, Invested Capital advanced 0.4% in 2022 and grew 11.49% in 2025.
- Over 5 years, Invested Capital stood at $18.5 billion in 2022, then increased by 6.88% to $19.8 billion in 2023, then advanced by 1.34% to $20.0 billion in 2024, then gained by 11.49% to $22.4 billion in 2025, then retreated by 0.24% to $22.3 billion in 2026.
- Per Business Quant data, the three most recent Invested Capital figures were $22.3 billion in Q2 2026, $22.2 billion in Q1 2026, and $22.4 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 22.30 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 12.77 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 5.47 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.58 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.33 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.30 Bn |
| Mar 31, 2026 | 22.18 Bn |
| Dec 31, 2025 | 22.35 Bn |
| Sep 30, 2025 | 21.25 Bn |
| Jun 30, 2025 | 21.28 Bn |
| Mar 31, 2025 | 20.32 Bn |
| Dec 31, 2024 | 20.05 Bn |
| Sep 30, 2024 | 20.48 Bn |
| Jun 30, 2024 | 19.97 Bn |
| Mar 31, 2024 | 19.88 Bn |
| Dec 31, 2023 | 19.79 Bn |
| Sep 30, 2023 | 19.44 Bn |
| Jun 30, 2023 | 19.53 Bn |
| Mar 31, 2023 | 19.11 Bn |
| Dec 31, 2022 | 18.51 Bn |
| Sep 30, 2022 | 18.33 Bn |
| Jun 30, 2022 | 18.12 Bn |
| Mar 31, 2022 | 18.56 Bn |
| Dec 31, 2021 | 18.17 Bn |
| Sep 30, 2021 | 18.00 Bn |